medi-cal glp 1 coverage BREAKING: Ends for Ozempic, Wegovy, Mounjaro & All GLP-1 Weight-Loss Drugs Jan 1, 2026, Sacramento, CA (Nov 2, 2025), California’s Medi-Cal will stop covering GLP-1 drugs (Ozempic, The GLP-1 Medical Weight Loss

Protein shakes may be easier to tolerate than solid foods during nausea because they require minimal digestion and provide controlled portions

Recommended Dosing Protocols Common bodybuilding and recovery-focused protocols include: Subcutaneous: 200500 mcg once or twice daily, near the injury site or in abdominal fat Intramuscular: 200300 mcg directly into the affected muscle, rotating sites Oral: 250500 mcg dissolved in water once daily, though bioavailability may vary Many protocols begin at the lower end, around 200 mcg, during the first week to assess tolerance

This tells the calculator how much active compound is available before reconstitution

Obesity is a chronic disease, and ongoing medical supervision supports better long-term outcomes

Safety Profile and Possible Side Effects Preclinical studies show BPC-157 was well-tolerated with no serious toxicity in mice, rats, rabbits, and dogs